Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Neurology Neuroimmunology & Neuroinflammation, 2026
Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis

Chitnis T., Singhal T., Zurawski J. et al.

Olink Target 48NeurologyPathophysiologySerum

Frontiers in Immunology, 2026
Circulating fibroblasts and neutrophils co-expressing CDH11+ and chemokine receptors in rheumatoid and psoriatic arthritis: a shared mechanism of ‘arthritis spreading’?

Kyriakidi M., Vetsika E., Fragoulis G. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Medicine, 2026
Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial

Donovan J., Duc Bang N., Dong H. et al.

Olink Explore 3072/384NeurologyInfectious DiseasesPatient StratificationCSF

Journal of Pediatric Gastroenterology and Nutrition, 2026
Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis

Eindor‐Abarbanel A., Moss‐ Ophir N., Agajany N. et al.

Olink Explore 3072/384GastroenterologyPathophysiologySerum

Blood Neoplasia, 2026
Proteome-wide Mendelian Randomisation Identifies Protein Associations and Therapeutic Targets for B-cell Malignancy

Went M., Mills C., Sud A. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Annals of the Rheumatic Diseases, 2026
Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach

Cross H., Peng J., McDonnell T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Cytotherapy, 2026
Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL

Lauener M., Normand M., Ngo T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture Supernatant

Metabolism, 2026
Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: A prospective cohort study

Huang Y., Zhang Y., Zhang Y. et al.

Olink Explore 3072/384Metabolic DiseasesCVDNephrologyPathophysiologyPlasma

mBio, 2026
Lineage-matched Oropouche virus mRNA-LNP vaccines confer complete, cross-protective immunity in mice

Yamada Y., Cha I., Kang S. et al.

Olink Target 48 MouseInfectious DiseasesPathophysiologyMouse Cell Culture Supernatant

FEBS Open Bio, 2026
Microglial dynamics and ferroptosis induction in human iPSC ‐derived neuron–astrocyte–microglia tri‐cultures

Li H., Ohmiya H., Sakamoto S. et al.

Olink Target 48NeurologyTechnical EvaluationCell Culture Supernatant

Lifestyle Genomics, 2026
Inflammatory proteins mediate the causal association between sleep traits and breast cancer: a Mendelian randomization study

Zhou J., Mao L.

Olink Target 96OncologyNeurologyPathophysiologyPlasma

Carcinogenesis, 2026
Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer

Xie X., Zhou J., Wu Q. et al.

Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma

Cell Metabolism, 2026
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night

Marjot T., Smith K., Westcott F. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma

HemaSphere, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy

Vänttinen I., Saad J., Ruokoranta T. et al.

Olink Target 48OncologyPatient StratificationBone Marrow Plasma

Aging Cell, 2026
The Secretome of Human Trophoblast Stem Cells Attenuates Senescence‐Associated Traits

Abdelmohsen K., Martindale J., Rossi M. et al.

Olink Target 96AgingPathophysiologyCell Culture SupernatantEV Lysate

Advanced Biology, 2026
Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood

Delemarre E., Smits H., van Baarle D. et al.

Olink Target 96AgingEpidemiologyEpidemiologyPlasma

Environment International, 2026
Molecular basis for the early life sensitization of the brain to ultrafine carbonaceous particles: a study of the brain proteome, telomeres, and epigenetic modelling

Vanbrabant K., Rasking L., Alfano R. et al.

Olink Target 96 MouseNeurologyEnvironmental Health & ToxicologyPathophysiologyMouse Tissue Lysate

Nature Medicine, 2026
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Fedak R., Ruggerie R., Shan Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesImmunotherapyPathophysiologySerum

European Journal of Heart Failure, 2026
Proteomic patterns according to ejection fraction: an EMPEROR-Program analysis

Ferreira J., Fioretti F., Sumin M. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Toxicology and Applied Pharmacology, 2026
Sinapic acid attenuates colistin-driven nephrotoxicity by targeting the miRNA-21/SIRT1/NF-κB pathway and facilitating tubular repair and inflammation in a rat model

Öz M., Şimşek H., Özdemir S. et al.

Olink Target 48 MouseInfectious DiseasesPathophysiologyRat Serum

3635 publications